Calculate the QT interval in patients taking drugs for dementia

No abstract is available for this paper.

• Publication year

  2007

• Venue

  British medical journal

• Publication date

  2007-09-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/BMJ.39020.710602.47PMID 17855324PMCID PMC1976518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excerpts from : The Discovery of Grounded Theory : Strategies for Qualitative Research

  2008cited by this paper
• Disadvantaged mothers, young children and smoking in the home: mothers' use of space within their homes.

  2007cited by this paper
• 'You think that I'm smoking and they're not': why mothers still smoke in the home.

  2007cited by this paper
• The social context of smoking: the next frontier in tobacco control?

  2006cited by this paper
• Legislation on smoking in enclosed public places in Scotland: how will we evaluate the impact?

  2006cited by this paper
• Blowing smoke: strategies smokers use to protect non-smokers from environmental tobacco smoke in the home

  2003cited by this paper
• 'I came back here and started smoking again': perceptions and experiences of quitting among disadvantaged smokers.

  2003cited by this paper
• "It's like an addiction first thing...afterwards it's like a habit": daily smoking behaviour among people living in areas of deprivation.

  2003cited by this paper
• Drug induced QT prolongation and torsades de pointes

  2003cited by this paper
• Reducing children's exposure to environmental tobacco smoke: the empirical evidence and directions for future research

  2000cited by this paper
• The 'considerate' smoker in public space: the micro-politics and political economy of 'doing the right thing'.

  2000cited by this paper
• QTc and psychotropic drugs.

  2000cited by this paper
• Reducing children’s exposure to environmental tobacco smoke in homes: issues and strategies

  1998cited by this paper

• Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patients

  2025cites this paper
• Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study

  2024cites this paper
• Potential Cardiologic Protective Effects of Acetylcholinesterase Inhibitors in Patients With Mild to Moderate Dementia.

  2023cites this paper
• Review of Medication in Patients with Dementia

  2021cites this paper
• NDT_A_324145 3791..3818

  2021cites this paper
• QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review

  2021cites this paper
• Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential

  2021cites this paper
• Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer’s Disease

  2021cites this paper
• QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine

  2020cites this paper
• Risk Factors for Cardiovascular Events in Patients on Antidementia Medications

  2020influential citation
• Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease

  2019cites this paper
• Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer’s Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model

  2019cites this paper
• Impact of Anti-Dementia Medication on the Risk of Death and Causes of Death in Alzheimer’s Disease

  2019cites this paper
• QT-interval prolongation due to medication found in the preoperative evaluation

  2017cites this paper
• Risk factors for cardiovascular events of antidementia drugs in Alzheimer's disease patients

  2016cites this paper
• Telemedicine for Dementia-Affected Patients: The AAL-ACCESS Project Experience

  2016cites this paper
• Acquired long QT syndrome and Torsades de Pointes related to donepezil use in a patient with Alzheimer disease

  2016cites this paper
• Multiple Source Annotation of ECG T-Waves for Measuring QT in Drug Development

  2015cites this paper
• QTc interval prolongation: a real concern or exaggerated threat?

  2014cites this paper
• Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.

  2014cites this paper
• Cardiovascular Effects of Drugs Used to Treat Alzheimer’s Disease

  2014cites this paper
• Cardiovascular pharmacodynamics of donepezil hydrochloride on the PR and QT intervals in patients with dementia

  2014cites this paper
• Het effect van galantamine op de ecg- geleidingstijden

  2014cites this paper
• Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease

  2014cites this paper
• FROM CARDIAC OPTICAL IMAGING DATA TO BODY SURFACE ECG: A THREE DIMENSIONAL VENTRICLE MODEL

  2014cites this paper
• Clinical and autonomic profile of patients with Alzheimer's disease and mixed dementia

  2013cites this paper
• Perfil clínico e autonômico de pacientes com doença de Alzheimer e demência mista

  2013cites this paper
• Clinical and autonomic profile of patients with Alzheimer's disease and mixed dementia patients.

  2013cites this paper
• Cardiac safety of donepezil in elderly patients with Alzheimer disease.

  2012cites this paper
• [Shortening of donepezil-induced QTc prolongation with a change in the interacting drug, after electrocardiograph monitoring by community pharmacists: a case report].

  2012cites this paper
• Marking the Ends of ECG T-Waves for Assessing Cardiac Safety: Algorithms and Experts

  2010cites this paper
• High Prevalence of Orthostatic Hypotension in Mild Dementia

  2009cites this paper